Profil
Rudi Pauwels is the founder of Biocartis Group NV (founded in 2007), Galapagos NV (founded in 1999), Virco Group NV (founded in 1995), and Galapagos Genomics NV (founded in 1999).
He held the title of Non-Executive Director at Biocartis Group NV from 2015 to 2018, Non-Executive Director at Galapagos NV from 2009 to 2010, and Chairman & Chief Scientific Officer at Virco Group NV from 1995 to 2002.
He was also the Chairman of Galapagos Genomics NV in 2002.
Dr. Pauwels is also the founder of Tibotec Virco NV.
Dr. Pauwels currently holds the position of Executive Chairman & Chief Executive Officer at Biocartis SA (since 2013).
He is also the Chairman of Benaruca SA, Executive Chairman & Partner at ANeuroTech BV, Director at Valetusan Ltd., Director at Cambenes SA, Director at Riverwells Investments SA, Director at Calimontes SL, Director at Caruso Inversiones SL, and Member of the Investment Committee at Smile Invest Management Co. NV.
Dr. Pauwels previously held the position of Chairman at RespiVert Ltd. He was an Independent Director at MDxHealth SA from 2013 to 2015.
He also served as a Director at MyCartis NV.
Additionally, he was a Venture Partner at Advent Venture Partners LLP from 2007 to 2011.
Dr. Pauwels obtained a doctorate degree from Katholieke Universiteit Leuven.
Postes actifs de Rudi Pauwels
| Sociétés | Poste | Début |
|---|---|---|
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Directeur Général | 02/07/2007 |
Benaruca SA
Benaruca SA MiscellaneousMiscellaneous Operates as a non-classified establishment | Président | - |
Cambenes SA | Directeur/Membre du Conseil | - |
Riverwells Investments SA | Directeur/Membre du Conseil | - |
Calimontes SL | Directeur/Membre du Conseil | - |
Caruso Inversiones SL | Directeur/Membre du Conseil | - |
Smile Invest Management Co. NV
Smile Invest Management Co. NV Investment ManagersFinance Smile Invest invests in companies located in Western Europe. The firm targets companies operating in the fields of Software & Tech Industries, Healthcare and Consumer Products & Services with an investment size ranging from €10 to €50 million and revenues of €10 to €150 million. It provides financing in the form of equity and debt for management buyouts and growth capital requirements. The firm acquires minority or majority stake in the company. | Private Equity Investor | - |
ANeuroTech
ANeuroTech Miscellaneous Commercial ServicesCommercial Services Develops proprietary small molecule | Président | - |
Anciens postes connus de Rudi Pauwels
| Sociétés | Poste | Fin |
|---|---|---|
Valetusan Ltd.
Valetusan Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business and management consultancy services | Directeur/Membre du Conseil | 31/12/2018 |
| ░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Rudi Pauwels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners invests in middle market companies located in the United Kingdom, Europe and the United States. The firm focuses on life sciences such as new drug discovery across all modalities, med tech, enabling technologies and vaccines. It participates in seed and early stage capital requirements. | Finance |
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
MDxHealth SA
MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Tibotec Virco NV
Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Develops drugs and individualized disease management products | Commercial Services |
Virco Group NV
Virco Group NV Miscellaneous Commercial ServicesCommercial Services Biotechnology company specialising in molecular biology, pharmacogenomics & artificial intelligence | Commercial Services |
Galapagos Genomics NV
Galapagos Genomics NV Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology Develops technologies for healthcare personalization needs | Health Technology |
RespiVert Ltd.
RespiVert Ltd. Medical DistributorsDistribution Services Operates as a small molecule drug discovery company | Distribution Services |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Benaruca SA
Benaruca SA MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Biocartis Group NV
Biocartis Group NV Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Valetusan Ltd.
Valetusan Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business and management consultancy services | Commercial Services |
Cambenes SA | |
Riverwells Investments SA | |
Calimontes SL | Finance |
Caruso Inversiones SL | |
Smile Invest Management Co. NV
Smile Invest Management Co. NV Investment ManagersFinance Smile Invest invests in companies located in Western Europe. The firm targets companies operating in the fields of Software & Tech Industries, Healthcare and Consumer Products & Services with an investment size ranging from €10 to €50 million and revenues of €10 to €150 million. It provides financing in the form of equity and debt for management buyouts and growth capital requirements. The firm acquires minority or majority stake in the company. | Finance |
ANeuroTech
ANeuroTech Miscellaneous Commercial ServicesCommercial Services Develops proprietary small molecule | Commercial Services |
















